Reference Information - Reference List

  1. Acosta, J., Catalan, M., Del Palacio-Peréz-Medel, A., Lora, D., Montejo, J.C., Cuetara, M.S., Moragues, M.D., Ponton, J., Del Palacio, A. (2010). A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-β-D-glucan chromogenic assay in serum samples. Clin. Microbiol. Infect. Article first published online: 5 NOV 2010, DOI: 10.1111/j.1469-0691.2010.03357.x.

  2. Ahmad, S., Khan, Z.U., and Theyyathel, A.M. (2007) Diagnostic value of DNA, (1→3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus. Diagn Microbiol Infect Dis. 59:165-71.

  3. Alexander, B.D., Smith, P.B., Davis, R.D., Perfect, J.R., Reller, L.B.. (2010). The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J. Clin. Microbiol. 48: 4083-8.

  4. Cuetara, M. S., Alhambra, A., Moragues, M.D., Gonzalez-Elorza, E., Ponton, J., and Del Palacio, A. (2009) Detection of (1→3)-β-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven fungal diseases or unusual clinical presentation. Clin. Vacc. Immunol. 16: 423-426.

  5. Del Bono, V., Mularoni, A., Furfaro, E., Delfino, E., Rosasco, L., Miletich, F., and Viscoli, C. (2009) Clinical evaluation of (1→3)-β-D-Glucan assay in presumptive Pneumocystis jirovecii pneumonia in immunocompromised patients. Clin. Vacc. Immunol. 16: 1524-1526.

  6. Del Palacio, A., Llenas-Garcìa, J., Soledad Cuétara, M., Pulido, F., Rubio, R., Pontón, J., Del Palacio-Pérez-Medel, A. (2010) Serum (1→3)-beta-D-Glucan as a noninvasive adjunct marker for the diagnosis and follow-up of Pneumocystis jirovecii pneumonia in patients with HIV infection. Clin Infect Dis. 50:451-2.

  7. Desmet, S., Van Wijngaerden, E., Maertens, J., Verhaegen, J., Verbeken, E., De Munter, P., Meersseman, W., Van Meensel, B., Van Eldere, J., Lagrou, K., (2009) Serum (1→3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol. 47:3871-4.

  8. Digby, J., Kalbfleisch, J., Glenn, A., Larsen, A., Browder, W., and Williams, D. (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin. Diagn. Laboratory. Immunol. 10: 802-805.

  9. Duffner, U., Abdel-Mageed, A., Dahl, K., Fogg, G., and Hester, J. (2011) Serum (1→3)-β-D-glucan levels (Fungitell assay) is not useful as a screening test for recipients of an allogeneic HSCT while on immunoglobulin replacement. Bone Marrow Transpl. (Epub ahead of print).

  10. Egan, L., Connolly, P., Wheat, L. J., Fuller, D., Davis, T. E., Knox, K. S. and Hage, C. A. (2007) Histoplasmosis as a cause for a positive FungitellTM (1→3)-β-D-glucan test, Medical Mycology, 46:1,93-95.

  11. Ellis, M., Ramadi, B., Finkelman, M., Hedstrom, U., Kristenson, J., Ali-Zadeh, H., and Klingspor, L. (2007) Assessment of the clinical utility of serial β-D-glucan concentrations in patients with persistent neutropenic fever. J. Med. Microbiol. 57: 287-95.

  12. Finkelman, M.A., (2010) Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan: Biology and diagnostic utility. Crit. Rev. Microbiol. 36: 271-81.

  13. Finkelman, M.A. and Tamura, H. (2005) Detection and measurement of (1→3)-beta-D-glucan. In "Toxicology of (1→3)-Beta-Glucans," Young, S.H. and Castranova, V, eds. CRC Press, New York.

  14. Girouard, G., Lachance, C., Pelletier, R. (2007) Observations on (1→3)-beta-D-glucan detection as a diagnostic tool in endemic mycosis caused by Histoplasma or Blastomyces. J Med Microbiol. 56:1001-2.

  15. Gonzales, B.E., Faverio, L.A., Marty, F.M., MacArthur, C., and Churchill, R.B. (2011) Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia. Clin. Vacc. Immunol. Epub prior to print. [doi:10.1128/CVI.00054-11].

  16. Hachem, R.Y., Kontoyiannis, D.P., Chemaly, R.F., Jiang, Y., Reitzel, R., and Raad, I. (2008) Utility of galactomannan enzyme immunoassay and (1→3)-beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J. Clin. Micro. 47: 129-133.

  17. Hale, T.W., Bateman, T.L., Finkelman, M.A., and Berens, P.D. (2009) The absence of Candida albicans in milk samples of women with symptoms of ductal candidiasis (2009) Breastfeeding Med. 4: 57-61.

  18. Held, J., Koch, M., Reischl, U., Danner, T., Serr, A. (2011) Serum (1→3)-beta-D-Glucan measurement as early indicator for Pneumocystis jirovecii pneumonia and evaluation of its prognostic value. Clin. Microbiol. Infect. 17: 595-602.

  19. Held, J. and Wagner, D. (2011) β-D-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia. Clin. Microbiol. Infect. Epub. DOI: 10.1111/j.1469-0691.2010.03452.x.

  20. Heyland, D., Jiang, X., Day, A.G., and Laverdiere, M. (2011) Serum β-d-glucan of critically ill patients with suspected ventilator-associated pneumonia Preliminary observations. J. Crit. Care. In Press.

  21. Karageorgopoulos, D.E., Vouloumanou, E.V., Ntziora, F., Michalopoulos, A. β-D-Glucan assay for the diagnosis of invasive fungal infections: A meta-analysis. Clin. Inf. Dis. 2011; 52: 750-770.

  22. Rafailidis, P. I., Falagas, M.E., Khan, Z.U., Ahmad, S., Mokaddas, E., Said, T., Nair, M.P., Halim, M.A., Nampoory, M.R., and McGinnis, M.R. (2007) Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1→3)-β-D-glucan in clinical specimens. J Med Microbiol. 56:129-32.

  23. Koo, S., Bryar, J.M., Page, J.H., Baden, L.R., and Marty, F.M. (2009) Diagnostic performance of the (1→3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis. 49:1650-9.

  24. Kondori, N., Edebo, L., and Mattsby-Baltzer, I. (2004) Circulating (1→3)-β-D-glucan and Immunoglobin G subclass antibodies to candia albicans cell wall antigens in patients with systemic candidiasis. Clinical and diagnostic Laboratory Immunology. 11(2):344-350.

  25. Marty, F.M., Lowry, C.M., Lempitski, S.J., Kubiak, D.W., Finkelman, M.A., and Baden, L. R., (2006) Reactivity of (1→3)-β-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob. Agents Chemo. 50: 3450-3453.

  26. Marty, F. M., Koo, S., Bryar,and J., and Baden, L.R. (2007) (1→3)-β-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann. Int. Med. 147: 70-72.

  27. Marty, F. M. and Koo, S. (2008) Role of (1→3)-β-D-glucan in the diagnosis of invasive aspergillosis. Medical Mycology 47: Suppl. 1: S233-240.

  28. Mennink-Kersten, M.A., Ruegebrink, D., Wasei, N., Melchers, W.J., and Verweij, P.E. (2006) In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol. 44:1711-8.

  29. Metan, G., Agkus, C., Buldu, H., Koç, A.N. (2010). The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections Infection. 38:217-21.

  30. Mikulska, M., Furfaro, E., Del Bono, V., Gualandi, F., Van Lint, M.T., Miletich, F., Bacigalupo, A., and Viscoli, C. (2011) Persistence of positive (1,3)-beta-glucan test after clearance of candidemia in HSCT recipients. Clin. Vacc. Immunol. 18: 518-519.

  31. Mohr, J.F., Sims, C., Paetznick, V., Rodriguez, J., Finkelman, M.A., Rex, J.H., and Ostrosky-Zeichner, L. (2010). A Prospective survey of (1→3)-β-D-glucan and its relationship to Invasive candidiasis in the surgical ICU setting. J Clin Microbiol. 49: 58-61.

  32. Mularoni, A., Furfaro, E., Faraci, M., Franceschi, A., Mezzano, P., Bandettini, R., Viscoli, C., and Castagnola, E. (2010) High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease. Clin Vaccine Immunol. 17:882-3.

  33. Obayashi, T., Negishi, K., Suzuki, T., and Funata, N. (2008) Reappraisal of the serum (1→3)-beta-D-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6 years. Clin. Infect. Dis. 46: 1864-1870.

  34. Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian,H., Saeki, F., Ridge, R., Ketchum, P., Finkelman, M., Rex, J. and Ostrosky-Zeichner, L. (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Clinical Infectious Diseases. 39:199-205.

  35. Odabasi, Z., Paetznick, V.L., Rodriguez, J.R., Chen, E., McGinnis, M.R., and Ostrosky-Zeichner, L. (2006) Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol. 44:267-72.

  36. Ostrosky-Zeichner, L., Alexander, B.D., Kett, D.H., Vazquez, J., Pappas, P.G., Saeki, F., Ketchum, P.A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M.A., and Rex, J.H. (2005) Multicenter clinical evaluation of the (1→3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Inf. Dis. 41: 299-305.

  37. Ostrosky-Zeichner, L., Paetznick, V.L., Rodriguez, J., Chen, E., and Sheehan, D.J. (2009) Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1→3)-β-D-glucan levels. Antimicrob. Agents Chemother. 53: 1639-1641.

  38. Pazos, C., Ponton, J., and Del Palacio, A. (2005) Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: A comparison with serial screening for circulating galactomannan. Journal of Clinical Microbiology 43(1): 299-305.

  39. Pazos, C., Moragues, M-D., Quindos, G., and del Palacio, A. (2006) Diagnostic potential of (1→3)-β-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients. Re. Iberoam Micol. 23: 209-215

  40. Persat, F., Ranque, S., Derouin, F., Michel-Nguyen, A., Picot, S., and Sulahian, A. (2008) Contribution of the (1→3)-β-D-glucan Assay for the Diagnosis of Invasive Fungal Infections. J. Clin. Micro. 36: 1009-1013.

  41. Petraitiene, R., Petraitis, V., Hope, W.W., Mickiene, D., Kelaher, A.M., Murray, H.A., Mya-San, C., Hughes, J.E., Cotton, M.P., Bacher, J., and Walsh, T.J. (2008) CSF and Plasma (1→3)-β-D-glucan as surrogate markers for detection and therapeutic response of experimental hematogenous candida meningoencephalitis. Antimicrobial Agents and Chemotherapy Antimicrob. Agents. Chemo. 52: 4121-4129.

  42. Pickering, J.W., Sant, H.W., Bowles, C.A., Roberts, W.L., and Woods, GL. (2005) Evaluation of a (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43:5957-62.

  43. Ponton, J. (2009) Usefulness of biological markers in the diagnosis of invasive candidiasis. Rev. Iberoam. Micol. 26:8-14.

  44. Sax, P.E. and Piscuilli, M.L. (2008), Use of a Serum β-D-Glucan Assay for Diagnosis of HIV-Related Pneumocystis jiroveci Pneumonia in Patients with Negative Microscopic Examination Results. CID 2008:46.

  45. Smith, P.B., Benjamin, D.K., Alexander, B.D., Johnson, M.D., Finkelman, M.A., and Steinbach, W.J. (2007) (1→3)-β-D-glucan levels in pediatric patients: Preliminary data for the use of the beta-glucan test in children. Clin. Vaccine Immunol. 14: 924-925.

  46. Racil, Z., Kocmanova, I., Lengerova, M., Weinbergerova, B., Buresova, L., Toskova, M., Winterova, J., Timilsina, S., Rodriguez, I., Mayer, J. (2010) Difficulties in using 1,3-beta-D glucan as the screening test for the early diagnosis of invasive fungal diseases in patients with hematological malignancies - high frequency of false positive results and their analysis. J Med Microbiol. 2010 May 20. [Epub ahead of print].

  47. Thornton, C.R. (2008) Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008 15:1095-105.

  48. Wiederhold, N.P., Najvar, L.K., Vallor, A.C., Kirkpatrick, W.R., Bocanegra, R., Molian, D., Olivo, M., Graybill, J.R., and Patterson, T.F. (2008) Assessment of (1→3)-β-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis Antimicrob. Agents and Chemotherapy. Antimicrob. Agents Chemother. 52; 1176-1178.
Back To Top
We Value Your Privacy

We use cookies to help give you the best experience on our site and to allow us and third parties to customize the marketing content you see across websites and social media. For more information see our Cookie Policy. Please be advised that Associates of Cape Cod, Inc. (ACC) has updated its Privacy Policy.